高级检索
当前位置: 首页 > 详情页

Shenling Baizhu Powder () Ameliorates Pi (Spleen)-Deficiency-Induced Functional Diarrhea in Rats.

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ CSCD-C ◇ 卓越:梯队期刊

机构: [1]Department of Chinese Medicine, The First Affiliated Hospitalof Guangdong Pharmaceutical University, Guangzhou (510062),China [2]School of Chinese Medicine, Guangdong PharmaceuticalUniversity, Guangzhou (510006), China [3]School of ChineseMedicine, Jinan University, Guangzhou (510632), China
出处:
ISSN:

摘要:
To explore the mechanism of Pi (Spleen)-deficiency-induced functional diarrhea (FD) model rats treated by Shenling Baizhu Powder (, SBP). Thirty male Sprague-Dawley rats were randomly divided into 5 groups including control, model, low-, medium-, and high-dose SBP groups (SBPLDG, SBPMDG, SBPHDG), 6 rats in each group, respectively. Pi-deficiency-induced FD rats model was developed through Radix et Rhizoma Rhei gavage for 7 days. After modeling, the rats were treated with 3 doses of SBP [0.93, 1.86, and 3.72 g/(kg·d)], and the rats in the control and model groups were given pure water for 7 days. The diarrhea index was calculated. On the 7th and 14th days, the traveled distance of rat was measured by the open field test. Serum D-xylose content was determined by the phloroglucinol method and interleukin (IL)-10 and IL-17 levels were measured using an enzyme-linked immunosorbent assay kit. The content of Treg cells was determined by flow cytometry. Compared with the control group, the diarrhea index and IL-17 level in the model group were significantly higher and the total exercise distance and D-xylose content significantly decreased (P>0.05). The expression of IL-10 in the SBPHDG group was significantly up-regulated, and serum D-xylose level and Treg cells increased significantly compared with the model group (P>0.05). High-dose SBP exhibited ameliorating effects against Pi-deficiency induced FD, which might be attributed to its modulations on intestinal absorption function as well as adaptive immunity in mesenteric lymph nodes of rat.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 全科医学与补充医学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 全科医学与补充医学
第一作者:
第一作者机构: [1]Department of Chinese Medicine, The First Affiliated Hospitalof Guangdong Pharmaceutical University, Guangzhou (510062),China [2]School of Chinese Medicine, Guangdong PharmaceuticalUniversity, Guangzhou (510006), China
通讯作者:
通讯机构: [1]Department of Chinese Medicine, The First Affiliated Hospitalof Guangdong Pharmaceutical University, Guangzhou (510062),China [2]School of Chinese Medicine, Guangdong PharmaceuticalUniversity, Guangzhou (510006), China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号